{"id":198559,"name":"VERACYTE, INC.","slug":"veracyte-inc","state":"CA","country":"United States of America","description":"Diagnostics company pioneering the field of molecular cytology.","totalSpending":660000,"filings":22,"yearlySpending":[{"year":2018,"income":120000},{"year":2019,"income":120000},{"year":2020,"income":120000},{"year":2021,"income":150000},{"year":2022,"income":150000}],"issues":["MMM","MED","HCR"],"firms":["TODD STRATEGY GROUP"],"lobbyists":["DANIEL TODD","PAUL EDATTEL","JEFF LUCAS"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Veterans Affairs, Dept of (VA)"],"sampleDescriptions":["Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. \nImplementation of changes to Medicare payments for clinical laboratory tests. \nMedicare treatment of outpatient rei","FDA regulation of laboratory developed tests.","Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. \nImplementation of changes to Medicare payments for clinical laboratory tests. \nMedicare treatment of outpatient rei","FDA regulation of laboratory developed tests.","Implementation of PL 113-93 (H.R. 4302): Protecting Access to Medicare Act of 2014. \nImplementation of changes to Medicare payments for clinical laboratory tests. \nMedicare treatment of outpatient rei"],"years":[2018,2019,2020,2021,2022]}